ArticleJournal of clinical and experimental hepatology2018

A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.

Gautam Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.